Under the agreement.

Under the agreement , Siemens will be responsible for the development of the test in accordance with certain plans and milestones, and Siemens and BG Medicine will collaborate in support of the development of the testing and regulatory submissions.

‘. Siemens Healthcare Diagnostics is to assist in the development of new and novel markers for diagnosis of cardiovascular disease we hired are delighted to cooperate with BG Medicine to the galectin-3 to develop biomarkers for our platforms, which we believe. Will be diagnosed in the development of tools to clinicians and to manage heart failure important, ‘said Dave Hickey, Chemistry / Immunoassay, Automation and Diagnostics IT Business Unit, Siemens Healthcare Diagnostics..Type 2 diabetes a particular concern for ethnic minorities, who are from developing countries but live in to the upper-middle of income and countries with high income. These people tend for have low socioeconomic status, and find that they are with lots of physics, communication and cultural barriers make it difficult to more effectively access health sector are confronted.

Other Posts From Category "men's health":

Related Posts